NEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), today announced …
Read More »
COPENHAGEN, Denmark, Aug. 31, 2020 /PRNewswire/ — H. Lundbeck A/S (Lundbeck) today announced headline results …
Read More »
SAN CARLOS, Calif., Sept. 2, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that …
Read More »
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology …
Read More »
SAN DIEGO & FORT WORTH, Texas–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the acquisition …
Read More »
NEW YORK & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) and Ovid Therapeutics Inc. …
Read More »
NORTH CHICAGO, Ill., Aug. 25, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that it has submitted …
Read More »
CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in …
Read More »
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE:BMY) today announced that the Phase 3 IDHENTIFY study evaluating IDHIFA® (enasidenib) plus …
Read More »
LONDON–(BUSINESS WIRE)–Engitix Ltd (‘Engitix’), a biotechnology company developing a portfolio of programmes in fibrosis and …
Read More »
SAN DIEGO, Aug. 25, 2020 (GLOBE NEWSWIRE) — Metacrine, Inc., a clinical-stage biopharmaceutical company focused …
Read More »
WALTHAM, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) — Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development …
Read More »
SAN DIEGO, Aug. 24, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a …
Read More »
ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (NASDAQ:EXEL) today announced the submission of a supplemental New Drug Application (sNDA) …
Read More »
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of …
Read More »
NEW YORK & MONTREAL–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) and Forbius, a privately held, clinical-stage protein …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
